The secondary purpose was to examine the correlation between the severity and extent of CAD, as assessed by the coronary artery calcium score (CACS), and serum levels of CTRP5 and chemerin in the CCTA-confirmed CAD group. This evidence concerns the gene RARRES2 and coronary artery disorder.